These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29857515)

  • 1. Bacterial Toxins and Targeted Brain Therapy: New Insights from Cytotoxic Necrotizing Factor 1 (CNF1).
    Tantillo E; Colistra A; Vannini E; Cerri C; Pancrazi L; Baroncelli L; Costa M; Caleo M
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model.
    Vannini E; Panighini A; Cerri C; Fabbri A; Lisi S; Pracucci E; Benedetto N; Vannozzi R; Fiorentini C; Caleo M; Costa M
    BMC Cancer; 2014 Jun; 14():449. PubMed ID: 24939046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Rac GTPase-activating bacterial protein toxin CNF1 induces analgesia up-regulating mu-opioid receptors.
    Pavone F; Luvisetto S; Marinelli S; Straface E; Fabbri A; Falzano L; Fiorentini C; Malorni W
    Pain; 2009 Sep; 145(1-2):219-29. PubMed ID: 19608345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiology of glioma: a Rho GTPase-activating protein reduces tumor growth and spares neuron structure and function.
    Vannini E; Olimpico F; Middei S; Ammassari-Teule M; de Graaf EL; McDonnell L; Schmidt G; Fabbri A; Fiorentini C; Baroncelli L; Costa M; Caleo M
    Neuro Oncol; 2016 Dec; 18(12):1634-1643. PubMed ID: 27298309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cnf1 Variants Endowed with the Ability to Cross the Blood-Brain Barrier: A New Potential Therapeutic Strategy for Glioblastoma.
    Colarusso A; Maroccia Z; Parrilli E; Germinario EAP; Fortuna A; Loizzo S; Ricceri L; Tutino ML; Fiorentini C; Fabbri A
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32375387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and cytoprotective activity of the small GTPase RhoB induced by the Escherichia coli cytotoxic necrotizing factor 1.
    Huelsenbeck SC; Roggenkamp D; May M; Huelsenbeck J; Brakebusch C; Rottner K; Ladwein M; Just I; Fritz G; Schmidt G; Genth H
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1767-75. PubMed ID: 23732113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of the Rho GTPase modulator CNF1 in a model of Parkinson's disease.
    Musilli M; Ciotti MT; Pieri M; Martino A; Borrelli S; Dinallo V; Diana G
    Neuropharmacology; 2016 Oct; 109():357-365. PubMed ID: 27350290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Bacterial Toxin CNF1 Induces Activation and Maturation of Human Monocyte-Derived Dendritic Cells.
    Gall-Mas L; Fabbri A; Namini MRJ; Givskov M; Fiorentini C; Krejsgaard T
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29738516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bacterial protein CNF1 as a new strategy against Plasmodium falciparum cytoadherence.
    Messina V; Loizzo S; Travaglione S; Bertuccini L; Condello M; Superti F; Guidotti M; Alano P; Silvestrini F; Fiorentini C
    PLoS One; 2019; 14(3):e0213529. PubMed ID: 30845261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The E. coli CNF1 as a pioneering therapy for the central nervous system diseases.
    Travaglione S; Loizzo S; Ballan G; Fiorentini C; Fabbri A
    Toxins (Basel); 2014 Jan; 6(1):270-82. PubMed ID: 24402235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTX-CNF1 Recombinant Protein Selectively Targets Glioma Cells In Vivo.
    Vannini E; Mori E; Tantillo E; Schmidt G; Caleo M; Costa M
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33800135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible senescence of human colon cancer cells after blockage of mitosis/cytokinesis caused by the CNF1 cyclomodulin from Escherichia coli.
    Zhang Z; Aung KM; Uhlin BE; Wai SN
    Sci Rep; 2018 Dec; 8(1):17780. PubMed ID: 30542142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-to-cell propagation of the bacterial toxin CNF1 via extracellular vesicles: potential impact on the therapeutic use of the toxin.
    Fabbri A; Cori S; Zanetti C; Guidotti M; Sargiacomo M; Loizzo S; Fiorentini C
    Toxins (Basel); 2015 Nov; 7(11):4610-21. PubMed ID: 26556375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CNF1 improves astrocytic ability to support neuronal growth and differentiation in vitro.
    Malchiodi-Albedi F; Paradisi S; Di Nottia M; Simone D; Travaglione S; Falzano L; Guidotti M; Frank C; Cutarelli A; Fabbri A; Fiorentini C
    PLoS One; 2012; 7(4):e34115. PubMed ID: 22523545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CNF1 Enhances Brain Energy Content and Counteracts Spontaneous Epileptiform Phenomena in Aged DBA/2J Mice.
    Travaglione S; Ballan G; Fortuna A; Ferri A; Guidotti M; Campana G; Fiorentini C; Loizzo S
    PLoS One; 2015; 10(10):e0140495. PubMed ID: 26457896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and proteasomal degradation of rho GTPases by cytotoxic necrotizing factor-1 elicit a controlled inflammatory response.
    Munro P; Flatau G; Doye A; Boyer L; Oregioni O; Mege JL; Landraud L; Lemichez E
    J Biol Chem; 2004 Aug; 279(34):35849-57. PubMed ID: 15152002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis.
    Davis JM; Carvalho HM; Rasmussen SB; O'Brien AD
    Infect Immun; 2006 Aug; 74(8):4401-8. PubMed ID: 16861625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New therapeutics from Nature: The odd case of the bacterial cytotoxic necrotizing factor 1.
    Maroccia Z; Loizzo S; Travaglione S; Frank C; Fabbri A; Fiorentini C
    Biomed Pharmacother; 2018 May; 101():929-937. PubMed ID: 29635902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-lasting efficacy of the cognitive enhancer cytotoxic necrotizing factor 1.
    Borrelli S; Musilli M; Martino A; Diana G
    Neuropharmacology; 2013 Jan; 64():74-80. PubMed ID: 22659407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the
    Carlini F; Maroccia Z; Fiorentini C; Travaglione S; Fabbri A
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.